Fabtech Technologies
144.09
+1.73(+1.22%)
Market Cap₹640.49 Cr
PE Ratio20.07
IndustryHealthcare
Company Performance:
1D+1.22%
1M-3.97%
6M-21.00%
1Y-21.00%
5Y-21.00%
View Company Insightsright
More news about Fabtech Technologies
14Feb 26
Fabtech Technologies Q3FY26 Earnings Call Reveals Revenue Timing Issues, Strong Order Book
Fabtech Technologies conducted its Q3FY26 earnings conference call on February 10, 2026, addressing revenue timing challenges while demonstrating strong business fundamentals. The company reported Rs 20.30 crores of deferred revenue due to shipment timing, maintained a robust order book of Rs 926.00 crores as of January 31, 2026, and reaffirmed its FY26 guidance of Rs 380-400 crores revenue with Rs 39-41 crores PAT, targeting 30% growth for FY27.
 no imag found
11Feb 26
Fabtech Technologies Makes Q3FY26 Earnings Call Recording Available Online
Fabtech Technologies Limited has released the recording of its Q3FY26 earnings conference call held on February 10, 2026, featuring key management personnel discussing unaudited financial results for the quarter and nine months ended December 31, 2025. The audio/video recording is now accessible through the company's website and was communicated to stock exchanges in compliance with SEBI regulations.
 no imag found
02Feb 26
Fabtech Technologies Reports Q3FY26 Results with ₹567.79L Loss and Risk Committee Dissolution
Fabtech Technologies announced Q3FY26 results showing consolidated net loss of ₹567.79 lakhs compared to ₹2,045.74 lakhs profit in Q3FY25, with revenue declining 39.84% year-over-year. The Board dissolved the Risk Management Committee and utilized ₹2,350.25 lakhs of IPO proceeds during the quarter.
 no imag found
19Dec 25
Fabtech Technologies Cleanrooms Secures ₹330 Million Order
Fabtech Technologies Cleanrooms has won a significant order worth ₹330 million in the cleanroom solutions sector. This large-scale contract demonstrates the company's capabilities in securing substantial projects and is expected to positively impact its revenue pipeline. The order reinforces Fabtech's competitive position and technical expertise in the specialized cleanroom technology market.
 no imag found
18Nov 25
Fabtech Technologies Clarifies Corporate Identity: Separate from Fabtech Technologies Cleanrooms Ltd
Fabtech Technologies Limited (FTL) has issued a statement to address market confusion, emphasizing its separate identity from Fabtech Technologies Cleanrooms Limited (FTCL). FTL and FTCL are independent, listed companies with distinct management teams and business strategies. FTL focuses on international turnkey life sciences infrastructure across 62 countries, while FTCL primarily serves India's cleanroom infrastructure needs. The companies have different stock listings, symbols, and ISINs. This clarification aims to prevent investor confusion and ensure accurate market representation.
 no imag found
14Nov 25
Fabtech Technologies Reports 109.9% Revenue Growth in H1 FY26, Expands Global Footprint
Fabtech Technologies Limited, a global turnkey engineering solutions provider for pharmaceutical sectors, reported robust H1 FY2026 results. Total income reached INR 19,322.80 lakhs, up 109.9% year-on-year. Net profit increased by 101.6% to INR 2,198.02 lakhs. EBITDA improved to INR 2,839.99 lakhs with margins at 14.7%. The company maintains a strong order book of INR 90,441.87 lakhs as of July 31, 2025, with 7-9% growth from July to September 2025. Operating in 22 countries, Fabtech focuses on MENA, GCC, and ECO Zone regions, offering end-to-end turnkey solutions for pharmaceutical manufacturing. The company's asset-light model and in-house manufacturing capabilities enhance execution agility and cost efficiency.
 no imag found
06Nov 25
Fabtech Technologies Reports Robust Q2 FY26 Results with 109.91% Revenue Growth, Targets Expansion in Bio-Pharma Sector
Fabtech Technologies Limited announced impressive Q2 FY26 results, with total income rising 109.91% YoY to ₹12,427.61 crores. Net profit surged 449.12% to ₹2,810.61 crores, while EBITDA margin expanded to 27.06%. The company's current order book stands at ₹90,441.87 lakhs, with operations across 62 countries. Fabtech is targeting growth in bio-pharma equipment, modular facilities, and engineering turnkey projects, leveraging its expertise in pharmaceutical and healthcare engineering solutions.
 no imag found
05Nov 25
Fabtech Technologies Reports Net Loss in Q1 FY26, Strong Rebound in Q2
Fabtech Technologies Limited reported a significant turnaround in Q2 FY26, with revenue increasing 78.6% to ₹12,148.07 lakhs and net profit reaching ₹2,810.61 lakhs, compared to a loss in Q1. The company completed its IPO and listed on NSE and BSE in October 2025. Additionally, Fabtech secured a ₹52 crore contract for a veterinary formulations facility in North Africa, boosting its order book to ₹983.05 crore. An earnings call is scheduled for November 10, 2025, to discuss Q1 and Q2 FY26 results.
 no imag found
03Nov 25
Fabtech Technologies Secures ₹52 Crore Contract for Veterinary Facility in North Africa
Fabtech Technologies Limited (FTL) has won a ₹52 crore contract to build a veterinary medicines manufacturing facility in North Africa's Maghreb region. The project includes complete design, engineering, cleanroom systems, utilities, and process equipment. This addition boosts FTL's cumulative order book to ₹983.05 crore. The Maghreb veterinary formulation market is projected to reach USD 500-700 million by 2030, driven by increasing demand for animal health products and food security goals. This contract marks FTL's strategic expansion in both human and animal healthcare sectors, leveraging its in-house capabilities to capitalize on growing markets.
 no imag found
Fabtech Technologies
144.09
+1.73
(+1.22%)
1 Year Returns:-21.00%
Industry Peers
Poly Medicure
1,334.20
(+3.97%)
Laxmi Dental
180.31
(+1.60%)
Tarsons Products
181.63
(+0.97%)
Osel Devices
515.25
(-0.04%)
Vasa Denticity
373.00
(+1.72%)
Fabtech Technologies
144.09
(+1.22%)
Prevest Denpro
380.35
(+5.65%)
Aprameya Engineering
211.20
(-0.71%)
Nureca
237.80
(+4.56%)